The search frequency for Jinwon Life Sciences, known as a specialized company in the development of gene therapies and gene vaccines, has surged recently.

As of 10:31 AM on the 9th, Jinwon Life Sciences' stock price is 9,490 KRW, down 1.15% from the previous day, with a trading volume of 631,124 shares, which is about 18.08% of the 5-day average trading volume. Foreign investors are tentatively estimated to have net purchased 15,401 shares today.

On June 3rd, Jinwon Life Sciences became a market issue with the news "US partner company COVID-19 vaccine clinical trial approval... upward trend."



[Table] Foreign and Institutional Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing